Isolated Lateral Extra-Articular Tenodesis for Ongoing Instability Following Anterior Cruciate Ligament (ACL) Reconstruction with an Intact Graft is Effective and Has Low Surgical Morbidity
The Journal of Knee Surgery · 01.03.2025 · 38 (04) · 207-215
DOI: 10.1055/a-2481-8771 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Knee Surgery, erschienen am 01.03.2025. Verfasst von Peter S E Davies und 7 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic Research Foundation of Western Australia, Perth, Western Australia. Hauptthemen laut MEDLINE: Tenodesis, Anterior Cruciate Ligament Reconstruction, Joint Instability, Anterior Cruciate Ligament Injuries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
The management of persisting instability following anterior cruciate ligament reconstruction (ACLR) includes isolated lateral extra-articular tenodesis (LEAT). The present study investigates the outcomes following isolated LEAT to address ongoing instability following ACLR without LEAT. Patients with ongoing symptomatic instability following ACLR with a radiologically intact and well-positioned graft who underwent an isolated LEAT between January 2017 and March 2022 were retrospectively recruited. Patients completed patient-reported outcome measures at baseline and mean 26 months postoperatively. Twelve knees in 11 patients underwent an isolated LEAT. All Knee Injury and Osteoarthritis Outcome Score domains improved significantly between pre- and postoperative measurements (pain 60.9–91.7, p = 0.002; symptoms 62.5–93.8, p = 0.003; activities of daily living 64.3–95.2, p = 0.002; sport 61.9–82.5, p = 0.012; quality of life 17.2–80.2, p = 0.002). One patient required revision ACL surgery 19 months following their subsequent LEAT procedure. An isolated LEAT demonstrated clinically significant improvements in patient function and activity with acceptable surgical morbidity and should be considered as an option for appropriate cases with instability despite an intact ACL graft. Level of evidence Level IV prospective case series
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Orthopaedic Research Foundation of Western Australia, Perth, Western Australia.
- Department of Trauma and Orthopaedics, Fiona Stanley and Fremantle Hospitals Group, South Metropolitan Health Service, Perth, Western Australia.
- School of Human Sciences (Exercise and Sport Science), University of Western Australia, Perth, Western Australia.
- HFRC Rehabilitation Clinic, Perth, Western Australia.
- School of Allied Health, Curtin University, Perth, Western Australia.
- Department of Trauma and Orthopaedics, Guy's and St Thomas' Hospital, London, United Kingdom.
ORCID-Profile: Peter S E Davies
Zitieren
APA
Davies, P. S. E., Muirhead, C., Mayne, A. I. W., Ebert, J. R., Edwards, P. K., Simpson, A., Williams, A., & D'Alessandro, P. (2025). Isolated Lateral Extra-Articular Tenodesis for Ongoing Instability Following Anterior Cruciate Ligament (ACL) Reconstruction with an Intact Graft is Effective and Has Low Surgical Morbidity. The Journal of Knee Surgery, 38(04), 207-215. https://doi.org/10.1055/a-2481-8771
Vancouver
Davies PSE, Muirhead C, Mayne AIW, Ebert JR, Edwards PK, Simpson A, et al. Isolated Lateral Extra-Articular Tenodesis for Ongoing Instability Following Anterior Cruciate Ligament (ACL) Reconstruction with an Intact Graft is Effective and Has Low Surgical Morbidity. The Journal of Knee Surgery. 2025;38(04):207-215. doi:10.1055/a-2481-8771
BibTeX
@article{Davies2025,
author = {Davies, Peter S E and Muirhead, Cameron and Mayne, Alistair I W and Ebert, Jay R and Edwards, Peter K and Simpson, Ashley and Williams, Andy and D'Alessandro, Peter},
title = {Isolated Lateral Extra-Articular Tenodesis for Ongoing Instability Following Anterior Cruciate Ligament (ACL) Reconstruction with an Intact Graft is Effective and Has Low Surgical Morbidity},
journal = {The Journal of Knee Surgery},
year = {2025},
volume = {38},
number = {04},
pages = {207--215},
doi = {10.1055/a-2481-8771}
}
EUVIMED